More on ORKA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-9.1% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Oruka Therapeutics (NQ:ORKA)
Delayed: 71.93 -1.94 (2.63%)
Prev. Close $73.87  
Open$73.75 
52 Wk High$ 
52 Wk Low$ 
Day High$74.26 
Day Low$70.50 
P/E N/A  
EPS$ 
Volume1,388,193 

Friends, Peers and Foes (?): HALO, CLDX, NBI, ABVX SYRE (more...)

Oct 15, 2026 06:15 PM Form 4 Oruka Therapeutics, Inc. For: Oct 15 Filed by: Goncalves Joana
Oct 15, 2026 04:38 PM Form 144 Oruka Therapeutics, Inc. Filed by: Goncalves Joana
Oct 13, 2026 04:34 PM Form 4 Oruka Therapeutics, Inc. For: Oct 12 Filed by: Agarwal Arjun
Oct 13, 2026 08:24 AM Form 144 Oruka Therapeutics, Inc. Filed by: Agarwal Arjun
Oct 7, 2026 09:15 AM Piper Sandler: 'We believe now is the time to own Oruka Therapeutics (ORKA)'
Oct 2, 2026 07:55 PM Form 4 Oruka Therapeutics, Inc. For: Oct 01 Filed by: Klein Lawrence Otto
Oct 1, 2026 04:23 PM Form 144 Oruka Therapeutics, Inc. Filed by: Klein Lawrence Otto
Sep 24, 2026 06:47 AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
Sep 23, 2026 07:02 AM Oruka's ORKA-001 shows deepening psoriasis response at week 28
Sep 23, 2026 07:00 AM Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing
View All Articles

Entities mentioned with ORKA

View All Entities